We serve Chemical Name:4-Nitrophenyl α-D-galactopyranoside CAS:7493-95-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Nitrophenyl α-D-galactopyranoside
CAS.NO:7493-95-0
Synonyms:4-nitrophenyl-alpha-D-galactoside;4-Nitrophenyl β-D-galactopyranoside;1-O-[P-NITROPHENYL]-β-D-GALACTOPYRANOSE;β-D-Galactopyranoside, 4-nitrophenyl (9CI);β-D-Galactopyranoside, 4-nitrophenyl;MFCD00065050;p-Nitrophenyl .α.-D-galactopyranoside;α-D-Galactopyranoside, 4-nitrophenyl;p-Nitrophenyl α-D-galactopyranoside;4-Nitrophenyl α-D-galactopyranoside;EINECS 231-343-6;p-Nitrophenyl β-D-galactopyranoside;4-Nitrophenyl a-D-galactopyranoside
Molecular Formula:C12H15NO8
Molecular Weight:301.249
HS Code:
Physical and Chemical Properties:
Melting point:166-169ºC
Boiling point:582.2±50.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.648
PSA:145.20000
Exact Mass:301.079773
LogP:-0.55
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 4-nitrophenyl-alpha-D-galactoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Nitrophenyl a-D-galactopyranoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-Nitrophenyl β-D-galactopyranoside Use and application,α-D-Galactopyranoside, 4-nitrophenyl technical grade,usp/ep/jp grade.
Related News: The pivotal TULIP (Treatment of Uncontrolled Lupus via the Interferon Pathway) phase III programme includes two trials, TULIP-1 and TULIP-2, that evaluated the efficacy and safety of anifrolumab versus placebo. gold,rubidium manufacturers J&J’s top brass told the group that its shot holds up against the Delta variant compared with older versions of the virus. After 8 months, the vaccine presents a similar antibody and T-cell response to Delta as it does with other concerning variants, J&J reported. rel-(5R,8S,9S,10S)-6,7,8,9,10-pentabromo-8,9-dihydro-5H-5,8-methanobenzo[7]annulene suppliers ICER’s researchers used a two-year treatment horizon in their model but noted that it’s unclear how long patients are supposed to remain on these treatments. The model may not fully capture the challenges the disease presents to patients, ICER acknowledged. rel-5-((1R,2S)-2-formylcyclopentyl)-1H-indole-3-carbonitrile vendor & factory.
